Home › BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX4430...
 

Keywords :   


BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX4430...

2014-12-15 18:43:01| Biotech - Topix.net

BioCryst Pharmaceuticals, Inc. today announced the dosing of the first subject in a randomized, placebo-controlled Phase 1 clinical trial to evaluate intramuscular administration of BCX4430 in healthy volunteers. BCX4430 is being developed as a potential treatment for hemorrhagic fever viruses, including Ebola virus and Marburg virus disease.

Tags: of trial phase clinical

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Atlantic Tropical Weather Outlook
29.09Eastern North Pacific Tropical Weather Outlook
29.09Hurricane Isaac Graphics
29.09Tropical Storm Joyce Graphics
29.09Hurricane Isaac Forecast Discussion Number 14
29.09Tropical Storm Joyce Forecast Discussion Number 8
29.09Hurricane Isaac Public Advisory Number 14
29.09Summary for Hurricane Isaac (AT5/AL102024)
More »